GlycoMimetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GlycoMimetics and other ETFs, options, and stocks.

About GLYC

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates.

CEO

Harout Semerjian

CEOHarout Semerjian

Employees

Employees35

Headquarters

Rockville, Maryland

HeadquartersRockville, Maryland

Founded

2003

Founded2003

Employees

Employees35

GLYC Key Statistics

Market cap

110.53M

Market cap110.53M

Price-Earnings ratio

-2.94

Price-Earnings ratio-2.94

Dividend yield

—

Dividend yield—

Average volume

1.05M

Average volume1.05M

High today

$1.78

High today$1.78

Low today

$1.64

Low today$1.64

Open price

$1.68

Open price$1.68

Volume

858.54K

Volume858.54K

52 Week high

$3.53

52 Week high$3.53

52 Week low

$1.11

52 Week low$1.11

GLYC News

Yahoo Finance 5d

We're Keeping An Eye On GlycoMimetics' Cash Burn Rate - Yahoo Finance

Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after li...